Correction to: Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Detalles Bibliográficos
Autores principales: Grimm, Sabine E., Witlox, Willem, Wolff, Robert, Chalker, Annette, Hiligsmann, Mickael, Wijnen, Ben, Ahmadu, Charlotte, Ryder, Steve, Armstrong, Nigel, Duffy, Steven, Syndikus, Isabel, Kleijnen, Jos, Joore, Manuela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095516/
https://www.ncbi.nlm.nih.gov/pubmed/35364758
http://dx.doi.org/10.1007/s40273-022-01144-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095516/
https://www.ncbi.nlm.nih.gov/pubmed/35364758
http://dx.doi.org/10.1007/s40273-022-01144-8

Ejemplares similares